Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12601105rdf:typepubmed:Citationlld:pubmed
pubmed-article:12601105lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:12601105lifeskim:mentionsumls-concept:C0015980lld:lifeskim
pubmed-article:12601105lifeskim:mentionsumls-concept:C0475463lld:lifeskim
pubmed-article:12601105lifeskim:mentionsumls-concept:C0205322lld:lifeskim
pubmed-article:12601105lifeskim:mentionsumls-concept:C0005508lld:lifeskim
pubmed-article:12601105pubmed:issue4lld:pubmed
pubmed-article:12601105pubmed:dateCreated2003-2-25lld:pubmed
pubmed-article:12601105pubmed:abstractTextMxA is an antiviral protein exclusively induced by type I interferons (IFN) and some viruses, and MxA gene expression is one of the most appropriate markers for measuring the biologic activity of exogenous IFNbeta.lld:pubmed
pubmed-article:12601105pubmed:languageenglld:pubmed
pubmed-article:12601105pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12601105pubmed:citationSubsetAIMlld:pubmed
pubmed-article:12601105pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12601105pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12601105pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12601105pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12601105pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12601105pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12601105pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12601105pubmed:statusMEDLINElld:pubmed
pubmed-article:12601105pubmed:monthFeblld:pubmed
pubmed-article:12601105pubmed:issn1526-632Xlld:pubmed
pubmed-article:12601105pubmed:authorpubmed-author:GiordanaM TMTlld:pubmed
pubmed-article:12601105pubmed:authorpubmed-author:BertolottoAAlld:pubmed
pubmed-article:12601105pubmed:authorpubmed-author:SalaAAlld:pubmed
pubmed-article:12601105pubmed:authorpubmed-author:MilanoEElld:pubmed
pubmed-article:12601105pubmed:authorpubmed-author:CapobiancoMMlld:pubmed
pubmed-article:12601105pubmed:authorpubmed-author:MelinAAlld:pubmed
pubmed-article:12601105pubmed:authorpubmed-author:GilloLLlld:pubmed
pubmed-article:12601105pubmed:authorpubmed-author:BotteroRRlld:pubmed
pubmed-article:12601105pubmed:authorpubmed-author:Di SapioAAlld:pubmed
pubmed-article:12601105pubmed:authorpubmed-author:MalucchiSSlld:pubmed
pubmed-article:12601105pubmed:authorpubmed-author:MarnettoFFlld:pubmed
pubmed-article:12601105pubmed:authorpubmed-author:LindbergR L...lld:pubmed
pubmed-article:12601105pubmed:issnTypeElectroniclld:pubmed
pubmed-article:12601105pubmed:day25lld:pubmed
pubmed-article:12601105pubmed:volume60lld:pubmed
pubmed-article:12601105pubmed:ownerNLMlld:pubmed
pubmed-article:12601105pubmed:authorsCompleteYlld:pubmed
pubmed-article:12601105pubmed:pagination634-9lld:pubmed
pubmed-article:12601105pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:12601105pubmed:meshHeadingpubmed-meshheading:12601105...lld:pubmed
pubmed-article:12601105pubmed:meshHeadingpubmed-meshheading:12601105...lld:pubmed
pubmed-article:12601105pubmed:meshHeadingpubmed-meshheading:12601105...lld:pubmed
pubmed-article:12601105pubmed:meshHeadingpubmed-meshheading:12601105...lld:pubmed
pubmed-article:12601105pubmed:meshHeadingpubmed-meshheading:12601105...lld:pubmed
pubmed-article:12601105pubmed:meshHeadingpubmed-meshheading:12601105...lld:pubmed
pubmed-article:12601105pubmed:meshHeadingpubmed-meshheading:12601105...lld:pubmed
pubmed-article:12601105pubmed:meshHeadingpubmed-meshheading:12601105...lld:pubmed
pubmed-article:12601105pubmed:meshHeadingpubmed-meshheading:12601105...lld:pubmed
pubmed-article:12601105pubmed:meshHeadingpubmed-meshheading:12601105...lld:pubmed
pubmed-article:12601105pubmed:year2003lld:pubmed
pubmed-article:12601105pubmed:articleTitlePersistent neutralizing antibodies abolish the interferon beta bioavailability in MS patients.lld:pubmed
pubmed-article:12601105pubmed:affiliationUnità dipartimentale: Centro Riferimento Regionale Sclerosi Multipla (CReSM) and Neurobiologia Clinica, Ospedale Universitario S. Luigi Gonzaga, Orbassano, Torino, Italy. NSGLB@tin.itlld:pubmed
pubmed-article:12601105pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:12601105pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:12601105pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:12601105pubmed:publicationTypeControlled Clinical Triallld:pubmed
pubmed-article:12601105pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12601105lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12601105lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12601105lld:pubmed